You just read:

Bayer Initiates Phase III Trial of Stivarga® (regorafenib) Tablets in Patients with Colorectal Cancer after Resection of Liver Metastases

News provided by

Bayer HealthCare Pharmaceuticals Inc.

Feb 20, 2014, 02:30 ET